Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR–Cas9 and ssODN in human cancer cells

Cited by papers we hold 3

• DNA Damage: From Threat to Treatment · 2020
  No notice
• Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks · 2020
  No notice
• CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.